Transcription factor 3 is dysregulated in megakaryocytes in myelofibrosis
Transcription factor 3 (TCF3) is a DNA transcription factor that modulates megakaryocyte development. Although abnormal TCF3 expression has been identified in a range of hematological malignancies, to date, it has not been investigated in myelofibrosis (MF). MF is a Philadelphia-negative myeloprolif...
Saved in:
| Main Authors: | Ryan J Collinson, Lynne Wilson, Darren Boey, Zi Yun Ng, Bob Mirzai, Hun S Chuah, Rebecca Howman, Carolyn S Grove, Jacques A J Malherbe, Michael F Leahy, Matthew D Linden, Kathryn A Fuller, Wendy N Erber, Belinda B Guo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Platelets |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09537104.2024.2304173 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Megakaryocyte contribution to bone marrow fibrosis: many arrows in the quiver
by: Alessandro Malara, et al.
Published: (2018-11-01) -
Clinical and hematological factors predicting the effectiveness of ruxolitinib in primary and secondary myelofibrosis. Results of a prospective single-center study
by: O. Yu. Vinogradova, et al.
Published: (2024-09-01) -
Assessing myelofibrosis burden on QoL and productivity from healthcare personnel and patient perspectives in India
by: Prantar Chakrabarti, et al.
Published: (2025-07-01) -
A comprehensive overview of patient journey and management decision pathway for myelofibrosis in India: INLAND survey
by: Prantar Chakrabarti, et al.
Published: (2025-07-01) -
Immune and Inflammatory Properties of Megakaryocytes
by: Shiv Vardan Singh, et al.
Published: (2025-07-01)